Phenotyping studies of clonotypic B lymphocytes from patients with multiple myeloma by flow cytometry

Archives of Pathology and Laboratory Medicine

Volumn 133, Issue 10, 2009, Pages 1594-1599

  Conway, E Joseph ^a   Wen, Jianguo ^a   Feng, Yongdong ^b   Mo, Albert ^a   Huang, Wan Ting ^c   Keever Taylor, Carolyn A ^d   Hari, Parameswaran ^d   Vesole, David H ^e   Chang, Chung Che ^a,f  

^a HOUSTON METHODIST HOSPITAL   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d MEDICAL COLLEGE OF WISCONSIN   (United States)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f Department of Obstetrics Gynecology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CD20 ANTIGEN; CD31 ANTIGEN; CD34 ANTIBODY; CD38 ANTIGEN; CHEMOKINE RECEPTOR CXCR4; IMMUNOGLOBULIN LIGHT CHAIN; INTERCELLULAR ADHESION MOLECULE 3; SYNDECAN 1;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; B LYMPHOCYTE; CANCER REGRESSION; CLINICAL ARTICLE; CLONAL VARIATION; CLONOTYPIC B LYMPHOCYTE; COMPLEMENTARITY DETERMINING REGION; CRYOPRESERVATION; CYTOPLASM; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT; HUMAN; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOPHENOTYPING; MALE; MULTIPLE MYELOMA; MYELOMA CELL; PATHOGENESIS; PHENOTYPE; PLASMA CELL; POLYMERASE CHAIN REACTION; PRE B LYMPHOCYTE; STEM CELL;

ADULT; AGED; B-LYMPHOCYTES; BONE MARROW; BONE MARROW TRANSPLANTATION; CLONE CELLS; DNA, NEOPLASM; FEMALE; FLOW CYTOMETRY; GENE REARRANGEMENT, B-LYMPHOCYTE, HEAVY CHAIN; HEMATOPOIETIC STEM CELL MOBILIZATION; HEMATOPOIETIC STEM CELLS; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOPHENOTYPING; MALE; MIDDLE AGED; MULTIPLE MYELOMA; NEOPLASM STAGING; PLASMA CELLS; REMISSION INDUCTION;

EID: 70349647600     PISSN: 00039985     EISSN: 15432165     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Silverberg E. Cancer statistics, 1985. CA Cancer J Clin. 1985;35(1):19-35.
2. Cancer Facts & Figures, 2007. Atlanta, GA: American Cancer Society; 2007.
3. Greipp PR. Advances in the diagnosis and management of myeloma. Semin Hematol. 1992;29(3, suppl 2):24-45.
4. Pilarski LM, Jensen GS. Monoclonal circulating B cells in multiplemyeloma: A continuously differentiating, possibly invasive, population as defined by ex pression of CD45 isoforms and adhesion molecules. Hematol Oncol Clin North Am. 1992;6(2):297-322.
5. Pilarski LM, Masellis-Smith A, Szczepek A, Mant MJ, Belch AR. Circulating clonotypic B cells in the biology of multiple myeloma: speculations on the origin of myeloma. Leuk Lymphoma. 1996;22(5-6):375-383. (Pubitemid 26341003)
6. + cells in the blood of patients with multiple myeloma express CD19 and IgH mRNA and have patient-specific IgH VDJ gene rearrangements. Blood. 1997;89(5):1824-1833.
7. Pilarski LM, Giannakipoulos NV, Szczepek AJ, Masellis AM, Mant MJ, Belch AR. In multiple myeloma, circulating hyperdiploid B cells have clonotypic immunoglobulin heavy chain rearrangements and may mediate spread of disease. Clin Cancer Res. 2000;6(2):585-596.
8. Kiel K, Cremer FW, Rottenburger C, et al. Analysis of circulating tumor cells in patients with multiple myeloma during the course of high-dose therapy with peripheral blood stem cell transplantation. Bone Marrow Transplant. 1999;23(10):1019-1027. (Pubitemid 29250847)
9. + cells in the peripheral blood of a patient with multiple myeloma. Br J Haematol. 1999;105(1):265-267.
10. + B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation. Br J Haematol. 1999;106(2):545-552.
11. + cells in patients with multiple myeloma. Blood. 2000;95(12):4020-4021.
12. Pilarski LM, Belch AR. Circulating monoclonal B cells expressing P glycoprotein may be a reservoir of multidrug-resistant disease in multiple myeloma. Blood. 1994;83(3):724-736.
13. Dreyfus F, Mell J, Quarre MC, Pillier C. Contamination of peripheral blood by monoclonal B cells following treatment of multiple myeloma by high-dose chemotherapy. Br J Haematol. 1993;85(2):411-412. (Pubitemid 23309582)
14. Bakkus MH, Van Riet I, De Greef C, Van Camp B, Thielemans K. The clonogenic precursor cell in multiple myeloma. Leuk Lymphoma. 1995;18(3-4):221-229.
15. Bakkus MH, Van Riet I, Van Camp B, Thielemans K. Evidence that the clonogenic cell in multiple myeloma originates from a pre switched but somatically mutated B cell. BR J Haematol. 1994;87(1):68-74. (Pubitemid 24207001)
16. Pilarski LM, Masellis-Smith A, Belch AR, Yang B, Savani RC, Turley EA. RHAMM, a receptor for hyaluronan-mediated motility, on normal human lymphocytes, thymocytes and malignant B cells: a mediator in B cell malignancy? Leuk Lymphoma. 1994;14(5-6):363-374. (Pubitemid 24282561)
17. Caligaris-Cappio F, Bergui L, Gregoretti MG, et al. Role of bone marrow stromal cells in the growth of human multiple myeloma. Blood. 1991;77(12):2688-2693.
18. + monoclonal B-lineage cells in peripheral blood from myeloma patients as late stage B cells. Blood. 1991;78(3):711-719.
19. Jensen GS, Belch AR, Mant MJ, Ruether BA, Pilarski LM. Expression of multiple adhesion molecules on circulating monoclonal B cells in myeloma. Curr Top Microbiol Immunol. 1992;182:187-193.
20. + peripheral blood cells expressing CD38, CD56, and monotypic Ig light chain. Blood. 1995;85(2):436-447.
21. Masellis-Smith A, Belch AR, Mant MJ, Turley EA, Pilarski LM. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Blood. 1996;87(5):1891-1899. (Pubitemid 26068905)
22. Szczepek AJ, Seeberger K, Wizniak J, Mant MJ, Belch AR, Pilarski LM. A high frequency of circulating B cells share clonotypic Ig heavy-chain VDJ rearrangements with autologous bone marrow plasma cells in multiple myeloma, as measured by single-cell and in situ reverse transcriptase-polymerase chain reaction. Blood. 1998;92(8):2844-2855. (Pubitemid 28469098)
23. Jensen GS, Belch AR, Mant MJ, Ruether BA, Yacyshyn BR, Pilarski LM. Expression of multiple beta 1 integrins on circulating monoclonal B cells in patients with multiple myeloma. Am J Hematol. 1993;43(1):29-36. (Pubitemid 23134579)
24. Cremer FW, Goldschmidt H, Moos M, Rasmussen T, Johnsen HE. Clonotypic B cells in the peripheral blood of patients with multiple myeloma. Blood. 2001;97(9):2913-2914.
25. Chen BJ, Epstein J. Circulating clonal lymphocytes in myeloma constitute a minor subpopulation of B cells. Blood. 1996;87(5):1972-1976. (Pubitemid 26068913)
26. Kimlinger T, Witzig TE. Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myeloma. Bone Marrow Transplant. 1997;19(6):553-556. (Pubitemid 27139780)
27. Epstein J, Xiao HQ, He XY. Markers of multiple hematopoietic-cell lineages in multiple myeloma. N Engl J Med. 1990;322(10):664-668. (Pubitemid 20089533)
28. Epstein J, Barlogie B, Katzmann J, Alexanian R. Phenotypic heterogeneity in aneuploid multiple myeloma indicates pre-B cell involvement. Blood. 1988;71(4):861-865. (Pubitemid 18111113)
29. Rasmussen T, Jensen L, Honore L, Andersen H, Johnsen HE. Circulating clonal cells in multiple myeloma do not express CD34 mRNA, as measured by single-cell and real-time RT-PCR assays. Br J Haematol. 1999;107(4):818-824. (Pubitemid 30020156)
30. Ozaki S, Kosaka M. Multiple myeloma: new aspects of biology and treatment. J Med Invest. 1998;44(3-4):127-136. (Pubitemid 128708036)
31. Pilarski LM, Belch AR. Intrinsic expression of the multidrug transporter, P-glycoprotein 170, in multiple myeloma: implications for treatment. Leuk Lymphoma. 1995;17(5-6):367-374.
32. Pilarski LM, Szczepek AJ, Belch AR. Deficient drug transporter function of bone marrow-localized and leukemic plasma cells in multiple myeloma. Blood. 1997;90(9):3751-3759.
33. Witzig TE, Li CY, Tefferi A, Katzmann JA. Measurement of the intensity of cell surface antigen expression in B- cell chronic lymphocytic leukemia. Am J Clin Pathol. 1994;101(3):312-317. (Pubitemid 24089578)
34. Sobol RE, Dillman RO, Collins H, Griffiths JC, Green MR, Royston I. Applications and limitations of peripheral blood lymphocyte immunoglobulin light chain analysis in the evaluation of non-Hodgkin's lymphoma. Cancer. 1985;56(8):2005-2010. (Pubitemid 15240875)
35. Hsu SM, Cossman J, Jaffe ES. Lymphocyte subsets in normal human lymphoid tissues. Am J Clin Pathol. 1983;80(1):21-30.
36. + selected versus unselected autologous peripheral blood progenitor cell transplantation in multiple myeloma. Blood. 1999;93(6):1858-1868.
37. Willems P, Croockewit A, Raymakrs R, et al. CD34 selections from myeloma peripheral blood cell autografts contain residual tumour cells due to impurity, not to CD34+ myeloma cells. Br J Haematol. 1996;93(3):613-622. (Pubitemid 26167368)
38. Steen R, Tjonnfjord GE, Gaudernack G, Brinch L, Egeland T. Differences in the distribution of CD34 epitopes on normal haemopoietic progenitor cells and leukaemic blast cells. Br J Haematol. 1996;94(4):597-605. (Pubitemid 26308889)
39. Serke S, Huhn D. Expression of class I, II and III epitopes of the CD34 antigen by normal and leukemic hemopoietic cells. Cytometry. 1996;26(2):154-160. (Pubitemid 26238189)
40. + bone marrow and peripheral blood stem cells. Scand J Immunol. 1998;47(1):82-90.
41. Steen R, Tjonnfjord GE, Groseth LA, Groseth LAG, Egeland T. Characteristics of haemopoietic progenitor cells related to CD34 epitope class expression. Eur J Haematol. 2000;64(4):245-251. (Pubitemid 30186782)
42. Matsui W, Huff C, Wang Q, et al. Characterization of multiple myeloma cells. Blood. 2004;103(6):2332-2336.
43. Matsui W, Want Q, Barber J, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res. 2008;68(1):190-197.
44. Singh KS, Clarke ID, Terasaki M, et al. Identification of a cancer stem cell in human brain tumors. Cancer Res. 2003;63(18):5821-5828. (Pubitemid 37187480)
45. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A. 2003;100(7):3893-3898. (Pubitemid 36418143)
46. Bedi A, Zehnbauer BA, Collector MI, et al. BCRABL gene rearrangement and expression of primitive hematopoietic progenitors in chronic myeloid leukemia. Blood. 1993;81(11):2898-2902. (Pubitemid 23162107)
47. Kay NE, Leong TL, Bone N, et al. Blood levels of immune cells predict survival in myeloma patients: results of an Eastern Cooperative Oncology Group phase 3 trial for newly diagnosed multiple myeloma patients. Blood. 2001;98(1):23-28.